(NASDAQ: SNY) Sanofi's forecast annual revenue growth rate of 0.38% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.64%.
Sanofi's revenue in 2025 is $50,740,000,000.On average, 24 Wall Street analysts forecast SNY's revenue for 2025 to be $57,324,298,447,143, with the lowest SNY revenue forecast at $53,538,719,652,306, and the highest SNY revenue forecast at $64,795,669,341,858. On average, 24 Wall Street analysts forecast SNY's revenue for 2026 to be $61,032,826,755,999, with the lowest SNY revenue forecast at $56,652,317,159,571, and the highest SNY revenue forecast at $68,893,239,448,782.
In 2027, SNY is forecast to generate $64,855,036,109,745 in revenue, with the lowest revenue forecast at $60,835,779,611,523 and the highest revenue forecast at $71,675,898,803,145.